Evidence map›Paper›PMID 38656769›Full record

ArticleJMIR public health and surveillance2024

A Machine Learning Model for Identifying Sexual Health Influencers to Promote the Secondary Distribution of HIV Self-Testing Among Gay, Bisexual, and Other Men Who Have Sex With Men in China: Quasi-Experimental Study.

Yuxin Ni, Ying Lu, Fengshi Jing, Qianyun Wang, Yewei Xie, Xi He, Dan Wu, Rayner Kay Jin Tan, Joseph D Tucker, Xumeng Yan and 8 more

Abstract read
In one paragraph

Article in JMIR public health and surveillance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuxin Ni *Dermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0003-0580-6946
Ying Lu *University of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-5057-1763
Fengshi Jing *Institute for Healthcare Artificial Intelligence Application, Guangdong Second Provincial General Hospital, Guangzhou, China.ORCID 0000-0002-6747-6527
Qianyun Wang *University of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-8558-8565
Yewei XieUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-9280-5812
Xi HeZhuhai Xutong Voluntary Services Center, Zhuhai, China.ORCID 0000-0003-0541-9962
Dan WuDepartment of Social Medicine and Health Education, School of Public Health, Nanjing Medical University, Nanjing, China.ORCID 0000-0003-0415-5467
Rayner Kay Jin TanUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0002-9188-3368
Joseph D TuckerUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0003-2804-1181
Xumeng YanUniversity of North Carolina at Chapel Hill Project-China, Guangzhou, China.ORCID 0000-0001-6677-2490
Jason J OngDepartment of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-5784-7403
Qingpeng ZhangMusketeers Foundation Institute of Data Science, The University of Hong Kong, Hong Kong, China (Hong Kong).ORCID 0000-0002-6819-0686
Hongbo JiangDepartment of Epidemiology and Biostatistics, School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China.ORCID 0000-0002-0631-4460
Wencan DaiZhuhai Center for Disease Control and Prevention, Zhuhai, China.ORCID 0000-0002-2012-3214
Liqun HuangZhuhai Center for Disease Control and Prevention, Zhuhai, China.ORCID 0009-0004-3133-3657
Wenhua MeiZhuhai Center for Disease Control and Prevention, Zhuhai, China.ORCID 0009-0008-5330-3570
Yi Zhou *Zhuhai Center for Disease Control and Prevention, Zhuhai, China.ORCID 0000-0001-6560-1059
Weiming Tang *Dermatology Hospital of Southern Medical University, Guangzhou, China.ORCID 0000-0002-9026-707X

Funding

Enhancing Partner Services among Men Who Have Sex with Men Living With HIV: A Pilot Randomized Controlled TrialR34MH119963 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TANG, WEIMING, TUCKER, JOSEPH DAVID · 2019 to 2021
$568k
NIMH NIH HHS R34 MH119963
6 · The paper itself

Abstract

backgroundSexual health influencers (SHIs) are individuals actively sharing sexual health information with their peers, and they play an important role in promoting HIV care services, including the secondary distribution of HIV self-testing (SD-HIVST). Previous studies used a 6-item empirical leadership scale to identify SHIs. However, this approach may be biased as it does not consider individuals' social networks.

objectiveThis study used a quasi-experimental study design to evaluate how well a newly developed machine learning (ML) model identifies SHIs in promoting SD-HIVST compared to SHIs identified by a scale whose validity had been tested before.

methodsWe recruited participants from BlueD, the largest social networking app for gay men in China. Based on their responses to the baseline survey, the ML model and scale were used to identify SHIs, respectively. This study consisted of 2 rounds, differing in the upper limit of the number of HIVST kits and peer-referral links that SHIs could order and distribute (first round ≤5 and second round ≤10). Consented SHIs could order multiple HIV self-testing (HIVST) kits and generate personalized peer-referral links through a web-based platform managed by a partnered gay-friendly community-based organization. SHIs were encouraged to share additional kits and peer-referral links with their social contacts (defined as "alters"). SHIs would receive US $3 incentives when their corresponding alters uploaded valid photographic testing results to the same platform. Our primary outcomes included (1) the number of alters who conducted HIVST in each group and (2) the number of newly tested alters who conducted HIVST in each. We used negative binomial regression to examine group differences during the first round (February-June 2021), the second round (June-November 2021), and the combined first and second rounds, respectively.

resultsIn January 2021, a total of 1828 men who have sex with men (MSM) completed the survey. Overall, 393 SHIs (scale=195 and ML model=198) agreed to participate in SD-HIVST. Among them, 229 SHIs (scale=116 and ML model=113) ordered HIVST on the web. Compared with the scale group, SHIs in the ML model group motivated more alters to conduct HIVST (mean difference [MD] 0.88, 95% CI 0.02-2.22; adjusted incidence risk ratio [aIRR] 1.77, 95% CI 1.07-2.95) when we combined the first and second rounds. Although the mean number of newly tested alters was slightly higher in the ML model group than in the scale group, the group difference was insignificant (MD 0.35, 95% CI -0.17 to -0.99; aIRR 1.49, 95% CI 0.74-3.02).

conclusionsAmong Chinese MSM, SHIs identified by the ML model can motivate more individuals to conduct HIVST than those identified by the scale. Future research can focus on how to adapt the ML model to encourage newly tested individuals to conduct HIVST.

trial registrationChinese Clinical Trials Registry ChiCTR2000039632; https://www.chictr.org.cn/showprojEN.html?proj=63068. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/s12889-021-11817-2.

Indexed as

Homosexuality, MaleMachine LearningSelf-TestingAdultChinaHIV InfectionsHumansMaleMiddle AgedSexual and Gender MinoritiesSexual HealthSurveys and Questionnairesartificial intelligenceHIV testingkey opinion leadersmachine learningmen who have sex with menself-testing

Identifiers

PMID38656769
PMCPMC11079758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.